Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of...

Johnson & Johnson (JNJ) has a valuation score of 82/100 (strong), profitability score of 87/100 (strong), financial health score of 74/100 (moderate), Piotroski F-Score of 5/9, Altman Z-Score of 4.69 (safe zone), revenue growth of +5.6% YoY.

Neutral

Analyst Consensus

Strong Buy

Wall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026

Analyst Recommendations31 analysts · 2026-08-01
7
15
9
Strong Buy 7Buy 15Hold 9Sell 0Strong Sell 0

Earnings

View earnings calendar →

Recent Earnings Results

DateTimeEPS Est.EPS ActualSurpriseRev Est.Rev Actual
Jul 15, 2026After-Hrs—————
Johnson & Johnson (JNJ) Valuation & P/E History →Johnson & Johnson (JNJ) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →